Profound Medical Corp (PRN) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.142x

Based on the latest financial reports, Profound Medical Corp (PRN) has a cash flow conversion efficiency ratio of -0.142x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-11.77 Million ≈ $-8.52 Million USD) by net assets (CA$82.93 Million ≈ $59.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PRN equity financing ratio to measure how much of total assets are equity-financed.

Profound Medical Corp - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Profound Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore debt repayment capacity of Profound Medical Corp to assess how comfortably operating cash covers total debt obligations.

Profound Medical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Profound Medical Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Peach Property Group AG SW:PEAN	-0.008x
Enel Generacion Costanera SA BA:CECO2	0.025x
Albatron Technology Co Ltd TWO:5386	0.357x
Grupo Ecoener S.A. MC:ENER	0.052x
Suzhou Jin Hong Shun Auto Parts Co Ltd Class A SHG:603922	-0.006x
Arbonia AG SW:ARBN	0.049x
Shenzhen Ruihe Construction Decoration Co Ltd SHE:002620	0.265x
Bombay Dyeing & Mfg Company Limited NSE:BOMDYEING	-0.019x

Annual Cash Flow Conversion Efficiency for Profound Medical Corp (2014–2025)

The table below shows the annual cash flow conversion efficiency of Profound Medical Corp from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Profound Medical Corp (PRN) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$91.06 Million ≈ $65.87 Million	CA$-53.39 Million ≈ $-38.62 Million	-0.586x	-51.03%
2024-12-31	CA$60.42 Million ≈ $43.71 Million	CA$-23.45 Million ≈ $-16.97 Million	-0.388x	+46.47%
2023-12-31	CA$31.18 Million ≈ $22.56 Million	CA$-22.61 Million ≈ $-16.36 Million	-0.725x	-46.16%
2022-12-31	CA$52.00 Million ≈ $37.62 Million	CA$-25.80 Million ≈ $-18.66 Million	-0.496x	-78.87%
2021-12-31	CA$80.62 Million ≈ $58.32 Million	CA$-22.36 Million ≈ $-16.17 Million	-0.277x	-31.24%
2020-12-31	CA$97.35 Million ≈ $70.42 Million	CA$-20.57 Million ≈ $-14.88 Million	-0.211x	+80.31%
2019-12-31	CA$14.29 Million ≈ $10.34 Million	CA$-15.33 Million ≈ $-11.09 Million	-1.073x	-56.19%
2018-12-31	CA$19.55 Million ≈ $14.14 Million	CA$-13.43 Million ≈ $-9.72 Million	-0.687x	+34.59%
2017-12-31	CA$11.25 Million ≈ $8.13 Million	CA$-11.81 Million ≈ $-8.55 Million	-1.050x	-7.46%
2016-12-31	CA$11.04 Million ≈ $7.98 Million	CA$-10.79 Million ≈ $-7.81 Million	-0.977x	-98.96%
2015-12-31	CA$10.06 Million ≈ $7.28 Million	CA$-4.94 Million ≈ $-3.58 Million	-0.491x	+76.65%
2014-12-31	CA$1.37 Million ≈ $989.71K	CA$-2.88 Million ≈ $-2.08 Million	-2.104x	--

About Profound Medical Corp

TO:PRN Canada Medical Devices

Market Cap

$272.52 Million

CA$376.73 Million CAD

Market Cap Rank

#15233 Global

#453 in Canada

Share Price

CA$10.38

Change (1 day)

+1.17%

52-Week Range

CA$5.35 - CA$12.11

All Time High

CA$35.63